Myriad Genetics buy The Goldman Sachs Group, Inc.
Start price
07.05.25
/
50%
€4.00
Target price
07.05.26
€7.05
Performance (%)
27.50%
Price
07:36
?
Summary
This prediction is currently active. The BUY prediction by The_Goldman_Sachs_Gr currently has a performance of 27.50%. This prediction currently runs until 07.05.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Myriad Genetics | 6.250% | 6.250% |
iShares Core DAX® | 1.043% | -0.149% |
iShares Nasdaq 100 | 1.920% | 4.604% |
iShares Nikkei 225® | 4.840% | 8.328% |
iShares S&P 500 | 1.567% | 3.310% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Myriad Genetics diskutieren
Myriad Genetics, Inc. (NASDAQ: MYGN) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $14.00 to $8.00. They now have a "buy" rating on the stock.
Ratings data for MYGN provided by MarketBeat